Cargando...
IMMU-20. SELECTING AN EPHA2-CAR FOR THE IMMUNOTHERAPY OF DIPG AND GBM
The intent of this project is to develop T cells expressing an EphA2-specific chimeric antigen receptor (CAR) as an immunotherapy for diffuse intrinsic pontine glioma (DIPG) and glioblastoma (GBM). EphA2 is an attractive target given its high expression in GBM but not normal brain tissue. We previou...
Guardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475122/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.130 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|